Institute of Cancer Research and Treatment of Candiolo

Turin 10060

1 studies enrolling now · 2 studies all time

What they study most

Myelodysplastic Syndromes, Squamous Cell Carcinoma of the Oropharynx

Studies at this site

• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — Recruiting now
• A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC — Status unconfirmed